A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection (PATRON)

This study has been terminated.
(Due to Interim Analysis and business concerns)
Sponsor:
Information provided by (Responsible Party):
Medigen Biotechnology Corporation
ClinicalTrials.gov Identifier:
NCT01402908
First received: July 25, 2011
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):